GSE195663 cisplatin 0 v 1 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE195663_cisplatin_0_v_1_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE195663_cisplatin_0_v_1_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE195663_cisplatin_0_v_1_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE195663_cisplatin_0_v_1_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

DExD-box helicase 52

Gene

Myb/SANT DNA binding domain containing 7

Gene

zinc finger protein 542, pseudogene

Gene

CENPB DNA-binding domain containing 1, pseudogene

Gene

ZNF667 antisense RNA 1

Gene

NUTM2A antisense RNA 1

Gene

GUSB pseudogene 1

Gene

ATP5MF-PTCD1 readthrough

Gene

arachidonate 12-lipoxygenase pseudogene 2

Gene

long intergenic non-protein coding RNA 540

  • Gene

    DExD-box helicase 52


  • Gene

    Myb/SANT DNA binding domain containing 7


  • Gene

    zinc finger protein 542, pseudogene


  • Gene

    CENPB DNA-binding domain containing 1, pseudogene


  • Gene

    ZNF667 antisense RNA 1


  • Gene

    NUTM2A antisense RNA 1


  • Gene

    GUSB pseudogene 1


  • Gene

    ATP5MF-PTCD1 readthrough


  • Gene

    arachidonate 12-lipoxygenase pseudogene 2


  • Gene

    long intergenic non-protein coding RNA 540

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.